Insulin degludec - A new-generation basal insulin

Ammar Wakil, Stephen Atkin

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Insulin degludec may provide dosing options for patients who, because of their lifestyle, require some flexibility in adhering to an insulin regimen, and it may also reduce the risk of hypoglycemia compared with the basal insulins that are currently available.

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalExpert Opinion on Biological Therapy
Volume12
Issue number5
DOIs
Publication statusPublished - May 2012
Externally publishedYes

Fingerprint

Insulins
Hypoglycemia
Life Style
Insulin
insulin degludec

Keywords

  • flexible dosing regimen
  • hypoglycemia
  • insulin degludec
  • type 1 and type 2 diabetes
  • ultra-long-acting basal insulin

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Insulin degludec - A new-generation basal insulin. / Wakil, Ammar; Atkin, Stephen.

In: Expert Opinion on Biological Therapy, Vol. 12, No. 5, 05.2012, p. 539-542.

Research output: Contribution to journalReview article

@article{ec405f5068394b16a6158a2bca44e705,
title = "Insulin degludec - A new-generation basal insulin",
abstract = "Insulin degludec may provide dosing options for patients who, because of their lifestyle, require some flexibility in adhering to an insulin regimen, and it may also reduce the risk of hypoglycemia compared with the basal insulins that are currently available.",
keywords = "flexible dosing regimen, hypoglycemia, insulin degludec, type 1 and type 2 diabetes, ultra-long-acting basal insulin",
author = "Ammar Wakil and Stephen Atkin",
year = "2012",
month = "5",
doi = "10.1517/14712598.2012.668880",
language = "English",
volume = "12",
pages = "539--542",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Insulin degludec - A new-generation basal insulin

AU - Wakil, Ammar

AU - Atkin, Stephen

PY - 2012/5

Y1 - 2012/5

N2 - Insulin degludec may provide dosing options for patients who, because of their lifestyle, require some flexibility in adhering to an insulin regimen, and it may also reduce the risk of hypoglycemia compared with the basal insulins that are currently available.

AB - Insulin degludec may provide dosing options for patients who, because of their lifestyle, require some flexibility in adhering to an insulin regimen, and it may also reduce the risk of hypoglycemia compared with the basal insulins that are currently available.

KW - flexible dosing regimen

KW - hypoglycemia

KW - insulin degludec

KW - type 1 and type 2 diabetes

KW - ultra-long-acting basal insulin

UR - http://www.scopus.com/inward/record.url?scp=84859617189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859617189&partnerID=8YFLogxK

U2 - 10.1517/14712598.2012.668880

DO - 10.1517/14712598.2012.668880

M3 - Review article

VL - 12

SP - 539

EP - 542

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 5

ER -